NR4A1 and breast carcinoma: Our results are in accordance with a recently published meta‐analysis by Robertson et al,14 which showed that patients with advanced hormone receptor + breast cancer with nonvisceral metastasis and visceral non‐liver metastasis had significantly better outcomes on endocrine therapy than patients with visceral liver metastasis.